Without domestic standards, Indian manufacturers have been relying on internal protocols or foreign manuals to manufacture weight-loss drugs, a market that CareEdge expects to cross $347 million in India sales by 2035.
​Without domestic standards, Indian manufacturers have been relying on internal protocols or foreign manuals to manufacture weight-loss drugs, a market that CareEdge expects to cross $347 million in India sales by 2035. by Soban News (international And National News)
